Saint-Herblain (France), May 4, 2022 – Valneva SE, a specialty vaccine company, today announced the initiation of a heterologous booster…
Since the interim results were released in March, patient enrollment has nearly doubledOf the 60 patients planned for the study,…
COPENHAGEN, Denmark – May 4, 2022 - Bavarian Nordic A/S (OMX: BAVA) will announce its 2022 first quarter results on…
MAULDIN, SC / ACCESSWIRE / May 4, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it signed a purchase…
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and…
HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will…
RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing…
HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of…
Brain Scientific partner LOK Corporation will illustrate the advantages of expanding EEG access with Brain Scientific’s neurology productsLAKEWOOD RANCH, Fla.,…
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2022, among other things, the following…